Xiaoran Wu
Impact in
- Condensed Matter Physics top 10%
- Micro and Nano Robotics
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- Metabolism, Diabetes, and Cancer 4
- Oncology 14
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Hewen Liu (4 shared papers)Na Zhao (6 shared papers)Xiongjie Zhu (7 shared papers)Yanfang Zheng (6 shared papers)Zhongjian Yu (5 shared papers)Zhile Liu (5 shared papers)Hong Qin (2 shared papers)Zhongqiang Zhao (1 shared paper)
In The Last Decade
Xiaoran Wu
41 papers receiving 659 citations
Peers
Comparison fields: 5 of 110
- Condensed Matter Physics 81
- Immunology 134
- Oncology 165
- Molecular Medicine 28
- Cancer Research 81
Countries citing papers authored by Xiaoran Wu
This map shows the geographic impact of Xiaoran Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoran Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoran Wu more than expected).
Fields of papers citing papers by Xiaoran Wu
This network shows the impact of papers produced by Xiaoran Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoran Wu. The network helps show where Xiaoran Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoran Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 118 | |
| 2 | 2021 | 115 | |
| 3 | 2016 | 79 | |
| 4 | 2020 | 34 | |
| 5 | 2013 | 31 | |
| 6 | 2021 | 31 | |
| 7 | 2022 | 31 | |
| 8 | Combination effect of curcumin with docetaxel on the PI3K/AKT/mTOR pathway to induce autophagy and apoptosis in esophageal squamous cell carcinoma. | 2021 | 25 |
| 9 | 2024 | 22 | |
| 10 | 2022 | 21 | |
| 11 | 2024 | 16 | |
| 12 | 2024 | 13 | |
| 13 | 2020 | 12 | |
| 14 | 2024 | 10 | |
| 15 | 2023 | 10 | |
| 16 | 2020 | 10 | |
| 17 | 2021 | 9 | |
| 18 | 2023 | 9 | |
| 19 | 2016 | 9 | |
| 20 | 2013 | 8 |
About Xiaoran Wu
Xiaoran Wu is a scholar working on Molecular Biology, Oncology, Immunology, Radiology, Nuclear Medicine and Imaging and Global and Planetary Change, having authored 50 papers that have together received 679 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (4 papers), Metabolism, Diabetes, and Cancer (4 papers), Computational Drug Discovery Methods (4 papers), Natural Antidiabetic Agents Studies (3 papers), Immune Cell Function and Interaction (3 papers) and Micro and Nano Robotics (3 papers). The work is most often cited by research in Condensed Matter Physics (81 citations), Immunology (134 citations), Oncology (165 citations), Molecular Medicine (28 citations) and Cancer Research (81 citations). Xiaoran Wu has collaborated with scholars based in China, Thailand and Macao. Frequent co-authors include Hewen Liu, Na Zhao, Xiongjie Zhu, Yanfang Zheng, Zhongjian Yu, Zhile Liu, Hong Qin, Zhongqiang Zhao, Lingyu Qin and Wei Li. Their work appears in journals such as Cancer Research, Bioorganic Chemistry, Journal of Clinical Oncology, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.